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ABSTRACT 
Rationale, aims and objectives: Randomization ensures that treatment groups do not differ 
systematically in their characteristics, thereby reducing threats to validity that may otherwise 
explain differences in outcomes. Large observed imbalances in patient characteristics may 
indicate that selection bias is being introduced into the treatment allocation process. We 
introduce classification tree analysis (CTA) as a novel algorithmic approach for identifying 
potential imbalances in characteristics and their interactions when provisionally assigning each 
new participant to one or the other treatment group. The participant is then permanently assigned 
to the treatment group that elicits either no, or less, imbalance than if assigned to the alternate 
group.   
Method: Using data on participant characteristics from a clinical trial, we compare three different 
treatment allocation approaches: permuted block randomization (the original allocation method), 
minimization, and CTA. Treatment allocation performance is assessed by examining balance of 
all 17 patient characteristics between study groups for each of the allocation techniques. 
Results: While all three treatment allocation techniques achieved excellent balance on main 
effect variables, CTA further identified imbalances on interactions, and in the distributions of 
some of the continuous variables. 
Conclusions: CTA offers an algorithmic procedure that may be used with any randomization 
methodology to identify and then minimize linear, non-linear, and interactive effects that induce 
covariate imbalance between groups. Investigators should consider using the CTA approach as a 
This article is protected by copyright. All rights reserved.
real-time complement to randomization for any clinical trial to safeguard the treatment allocation 
process against bias. 
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1. INTRODUCTION 
The randomized controlled trial (RCT) is considered the gold standard study design because 
randomization ensures that treatment groups do not differ systematically in their characteristics. 
However, the randomization process may still produce between-group differences that may 
explain observed differences in outcomes, and thus constitute a threat to statistical conclusion 
validity [1,2]. 
 A common approach for assessing the effectiveness of the randomization process is to 
examine the balance (i.e. comparability between distributions) of observed baseline 
characteristics among study groups [3,4]. Whereas a few small imbalances are expected by 
chance, larger imbalances may be indicative of selection bias in the treatment allocation process. 
The latter case necessitates the use of techniques that model the treatment assignment to adjust 
for these imbalanced characteristics that otherwise compromise causal interpretation of the 
results (see for example, [5-9]).  
 Given the large investment and organizational complexity required to properly conduct 
an RCT, it is prudent for study administrators to employ strategies throughout the entire trial that 
safeguard the treatment allocation process against systematic bias. Minimization is a strategy 
specifically designed to reduce imbalances between treatment groups on a predefined set of 
categorized patient characteristics [10,11]. It is implemented after the first participant enrolled in 
the study is randomly assigned to a treatment group, and allocates each subsequent participant to 
the treatment arm that minimizes the imbalance on one or more of the selected characteristics, 
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cumulatively until that point in time. The procedure allows for probabilistic treatment allocation 
(where 1.0 means that the patient is always assigned to the group that minimizes imbalances, and 
0.50 is equivalent to a coin flip) as well as the ability to assign weights to characteristics deemed 
more important than others (e.g. variables thought to be prognostic of the outcome)[11].  
 In a systematic review of the minimization literature, Scott et al [12] report that in the 
majority of cases, minimization outperforms simple randomization in achieving balanced groups 
(particularly when trial sample sizes are small), and it holds an advantage over stratified 
randomization methods due to its ability to incorporate more prognostic factors. Moher et al [3] 
contend that minimization offers the only acceptable alternative to randomization, while 
Treasure and MacRae [13] assert that minimization is actually superior to randomization. 
 In this paper, we introduce classification tree analysis (CTA) [14,15] as a novel and more 
robust approach to minimizing imbalances. CTA is a machine learning algorithm that can 
identify potentially complex patterns in the data that distinguish patients assigned to the different 
treatment arms in a clinical trial. In contrast to existing techniques that require the investigator to 
determine which variables to include, how to categorize continuous and multi-categorical 
variables, and which variables should be interacted (if any), CTA performs all these functions 
algorithmically, and if/as necessary, revises the allocation as each new participant is enrolled in 
the trial to minimize imbalances. 
 This paper is organized as follows. In the Methods section we describe the data used in 
the current study, provide a brief introduction to CTA, and explain the analytic framework used 
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to minimize imbalances on patient characteristics. The Results section reports and compares the 
results of the proposed CTA approach (which is implemented as a complement to 
randomization) to that of the original block randomization, and to the commonly-used 
minimization algorithm proposed by Pocock & Simon [11]. The Discussion section describes the 
specific advantages of the CTA approach over existing approaches and considers potential 
limitations. 
2. METHODS 
2.1 Data 
We use data from a parallel-group, stratified, clinical trial that examined whether a 
comprehensive, hospital-based, transitional care intervention reduces readmissions for 
participants with congestive heart failure (CHF) and chronic obstructive pulmonary disease 
(COPD) [16]. The intervention involved nurses implementing motivational interviewing-based 
health coaching to improve patients’ health behaviors, which in turn was expected to empower 
patients to better manage their own health care and reduce unplanned readmissions [17-19]. For 
the present study, we limit our analysis to the CHF cohort (N=257), for which baseline 
characteristics include: demographic variables (gender, age, insurance type, living conditions); 
patient activation measure (PAM) score; prior year hospital utilization (admissions, average 
length of stay, and emergency department visits) both for CHF as well as for all causes; average 
length of stay for the index hospitalization; and the presence of seven key comorbidities (COPD, 
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cerebrovascular disease, acute myocardial infarction, diabetes, renal disease, chronic pain, and 
obesity).  
2.2 Brief introduction to classification tree analysis (CTA) 
In its simplest form, CTA is an optimal discriminant analysis (ODA) model [20]. For any given 
application, the ODA algorithm identifies the cutpoint for an ordered attribute (independent 
variable), or the assignment rule for a categorical attribute, that most accurately (optimally) 
discriminates between two (or more) categories of the class (dependent) variable [21]. This 
entails computing the effect strength for sensitivity (ESS) obtained using every possible cutpoint 
along the continuum of values (or every possible rule) to classify sample observations. ESS is the 
mean sensitivity obtained over class categories at the cutpoint (or via the rule) used to classify 
observations, standardized to a 0%-100% scale on which 0% represents the level of accuracy 
expected by chance; 100% represents perfect accuracy; and negative values indicate accuracy 
worse than expected by chance. By definition, the optimal model uses the assignment rule that 
yields the greatest ESS value. Statistical significance is assessed via permutation probability, and 
validity analyses (e.g., jackknife, hold-out) are conducted to estimate potential cross-
generalizability of the model in correctly classifying new subjects that may differ in their 
characteristics compared to subjects in the original sample [14,22]. CTA constructs optimal 
models by chaining multiple ODA models together [23]. CTA models classify observations into 
one of two or more subgroups represented as model endpoints (terminal nodes) called “strata” 
because the sample is stratified into subgroups that are homogeneous within, and heterogeneous 
This article is protected by copyright. All rights reserved.
between, the different endpoints defined by the attributes and corresponding optimal 
cutpoints/rules selected by the CTA model [14,24]. 
2.3 Analytic approach 
This study compares the efficacy of three different treatment allocation approaches for producing 
treatment cohorts that are balanced on observed baseline characteristics.  
2.3.1. Permuted block randomization  
The first treatment allocation approach is the original randomization process used in Linden & 
Butterworth [16] and serves as the basis for comparison. Prior to study commencement, a 
randomization sequence was generated to allocate participants to treatment arms using random 
permuted blocks [25]. There were four strata (two hospitals and two disease conditions) and five 
permuted blocks allocated in equal proportions, with a minimum size of two and maximum size 
of ten. The treatments were allocated in a 1:1 ratio, with 18 extra allocations provided to 
maintain the integrity of the final block in each stratum. The allocation sequence was concealed 
via sequentially-numbered, opaque sealed envelopes. After each participant signed the consent 
form and provided baseline information, the envelope was opened by study staff in their 
presence, simultaneously revealing the treatment allocation to both participant and study staff. 
2.3.2. Minimization  
The second treatment allocation approach applies the Pocock & Simon [11] minimization 
technique, which requires all variables (“factors”) to be categorized. Given that there is no rule-
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of-thumb regarding how best to categorize continuous variables, we generated categories with 
relatively few levels that maintain sufficient sample size. The seven continuous variables were 
categorized as follows. Age was categorized into four age-bands: 20-39; 40-59; 60-79; 80+. 
Patient Activation Measure (PAM) scores were categorized into 3 quantiles: 16.5-47.4; 49.9 - 
56.4; 60-100. All-cause hospitalizations were categorized into four levels: 1, 2, 3, and 4+. All-
cause emergency department visits were categorized into five levels: 0, 1, 2, 3, and 4+. CHF-
specific hospitalizations were categorized into four levels: 0, 1, 2, 3. CHF-specific length of stay 
was categorized into four levels: 0; 1-3; 4-6; 7+. And finally, the length of stay of the index 
admission was categorized into three levels: 1-3; 4-6; 7+. All categorical variables were left in 
their original number of levels. 
 Each study participant was assigned to treatment in the same sequence in which they 
were originally enrolled in the trial. Each of the 257 participant’s 17 factors were entered into the 
Stata user-written command RCT_MINIM [26], with the first participant randomly assigned to 
treatment, and all subsequent participants automatically allocated to the treatment arm that 
produced the least imbalance between groups. No weights were utilized in the computations, 
given the extensive number of variables available and the belief that they all have prognostic 
value. 
2.3.3. CTA-based minimization  
The original study randomization sequence (see Section 2.3.1) served as the basis for the CTA 
approach. This ensures that the treatment assignment process cannot be deciphered (and the 
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allocation process potentially compromised), even if CTA indicates that changes to individual 
allocations must be made along the way. The first 6 participants were randomized according to 
the original sequence, because a minimum sample of 7 is needed to identify a statistically 
significant model [14]. 
 Commencing with the 7th participant, a CTA model was sought in which the 17 
independent variables (in their original measurement scale) were used to discriminate between 
treatment groups -- including all six participants enrolled in the trial thus far, and including the 
7th participant allocated to the treatment arm by block randomization sequencing. If no CTA 
model could be generated (i.e. indicating that no imbalances were found across any variable or 
interactions between subsets of variables), then the participant was assigned to the treatment 
group as was originally intended. However, if a CTA model could be generated, then the 
participant was provisionally given the alternate treatment assignment and a CTA model was 
again sought. If no CTA model could be generated under this provisional assignment, then the 
participant would be permanently allocated to this treatment arm. In the case where a CTA 
model could be generated for both provisional treatment assignments, then the participant would 
be permanently allocated to the arm that elicited the CTA model with the lowest ESS value 
(indicating that this treatment assignment was less biased than the alternate assignment). This 
process was repeated sequentially for each of remaining individuals in the study. 
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 To maximize expositive clarity, CTA models generated by the process are provided to 
illustrate interactive and parabolic imbalances that were identified, and corrected, by the CTA 
approach. 
2.4 Performance metrics for treatment allocation approaches 
To assess the performance of the three treatment allocation approaches, we examine how well 
each one avoided imbalances in baseline characteristics between treatment groups for the total 
study population, using two different methods.  
 First, we apply the conventional method of testing for differences, using χ2 tests for 
categorical variables and t-tests for continuous variables.  
Second, we apply the method described by Linden & Yarnold [27] that uses ODA to 
assess balance of characteristics between groups. In contrast to conventional tests for difference 
in means (or proportions), the ODA approach is insensitive to skewed data and outliers, and it 
additionally identifies a cutpoint (or rule) along the distribution of the characteristic that 
distinguishes between treatment assignments. The underlying assumption is that if treatment 
groups cannot be distinguished based on the distribution of each characteristic, then the treatment 
allocation was successful. In this framework, sensitivity, specificity, and ESS are used as balance 
diagnostics. 
3. RESULTS 
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Table 1 presents the baseline characteristics of the study population, under all three treatment 
allocation methods. As shown, there is virtually no difference among methods in achieving close 
balance between treatment groups using conventional statistical tests. 
 Table 2 presents the baseline characteristics of the study population under all three 
treatment allocation methods, analyzed using ODA. Summary values represent the cutpoint (or 
rule) on the characteristic. Sensitivity is presented for the intervention group, and specificity is 
presented for the group assigned to usual care (control condition). All three allocation methods 
achieved balance for all of the characteristics under study (as indicated by a consistently weak 
ESS across all characteristics, and supported by non-statistically significant P values > 0.05). 
With the exception of age, ODA identified the same cutpoint for all characteristics in the CTA 
approach and in the original block randomization (with similar sensitivity/specificity values), 
while identifying different cutpoints (and sensitivity/specificity values) for the minimization 
technique. In all, CTA identified eight cases of imbalance, all of which were successfully 
eliminated in the following (subsequent) step of the procedure. 
 Figure 1 illustrates four cases in which CTA identified imbalanced characteristics when 
provisionally assigning a new patient to the pre-specified (via the original permuted block 
randomization) treatment arm. As shown, these imbalances were due to interactions between 
variables or a parabolic function of a single variable. In Figure 1a, an interaction was identified 
between a participant’s living condition and gender, while Figure 1b illustrates an interaction 
between a participant’s number of prior year hospital days for CHF and the length of stay of the 
This article is protected by copyright. All rights reserved.
index hospitalization. Figures 1c and 1d both indicate that age has a non-linear relationship with 
treatment assignment 
3. DISCUSSION 
Although CTA has been recently applied to observational study data for improving causal 
inference [24,27-33], this paper focuses on its use in support of participant assignment in clinical 
trials. Using data from a permuted block randomized RCT [16], on the basis of conventional 
criteria we found that both minimization and CTA methods achieved balance on observed 
characteristics equally as well as the randomization method employed in the original study.   
 However, the CTA approach offers several key advantages over the other two methods 
that are not readily apparent from the baseline characteristics tables. First, CTA inherently finds 
interactions and nonlinear (e.g. parabolic) effects among variables that are unlikely to be 
identified manually (Figure 1). As a result, CTA ensures that balance is achieved not only in 
main effects, but also in all possible non-linear and interactive effects -- which could also serve 
to limit statistical conclusion validity. 
Second, whereas minimization requires the investigator to create categories for 
continuous variables (or rules for categorical variables) the resulting cutpoints (assignment rules) 
are unlikely to yield the maximum-possible discrimination between groups. In contrast, CTA 
intrinsically identifies the maximally-accurate cutpoint (rule) for each variable, ensuring that 
variables are optimally categorized to maximize accurate discrimination of participants in 
different groups [14]. 
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Third, as new participants are enrolled in the study, CTA attempts to identify new models 
based on updated variable cutpoints (or rules) and new interactions. Thus, CTA is a dynamic 
assignment process, whereas minimization relies strictly on the factors as they were originally 
conceived. Finally, the CTA approach integrates with any randomization sequencing procedure 
(e.g. the permuted block randomization process used in the present study), which mitigates 
concerns that treatment assignment derived using CTA may be predicted with certainty, and thus 
potentially manipulated (which in turn, will impact the validity of study outcomes). This 
advantage is verified by reviewing Table 2, which shows nearly identical values (for all metrics) 
were derived for the CTA and the block randomization approaches. 
 While the CTA approach has clear advantages, it also shares some of the same potential 
limitations as the minimization technique when compared to conventional randomization 
methods. First, implementation of the procedure is naturally more complex than simply 
generating the randomization sequence prior to initiation of the study. CTA requires real-time, 
manual entry of each new participant’s characteristics into the software in order to determine 
treatment assignment. While this process is mechanically straight-forward, it does necessitate 
that an administrator is available when participants are enrolled into the study. Another potential 
limitation is that a perfectly non-confounded allocation sequence may not be possible. In this 
case, the outcome model should be adjusted for the non-random covariates (and interactions) 
identified in the allocation procedure in order to obtain accurate results. This concern has been 
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raised in the context of the minimization technique [12], and the use of CTA-based propensity 
scores to make such adjustments was recently demonstrated [32]. 
4. CONCLUSION 
In summary, this paper introduces a novel machine learning approach for minimizing imbalances 
on patient characteristics between treatment groups in randomized trials. This approach offers 
several advantages over existing approaches, such as an algorithmic procedure to identify 
variables and interactions that induce imbalance, identifying the optimal (maximum-accuracy) 
cutpoints (or classification rules) on those variables, and integrating with any randomization 
procedure to ensure validity of the study outcomes. Therefore, investigators should consider 
using the CTA approach as a real-time complement to randomization for any clinical trial as a 
means of safeguarding the treatment allocation process against selection bias. 
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Table 1. Baseline characteristics of study participants, assigned to treatment under three different allocation methods 
 
  Block randomization   Minimization   Classification Tree Analysis   
Characteristic Treatment (N = 129) 
Control  
(N = 128) P 
Treatment 
(N = 129) 
Control 
(N = 128) P 
Treatment 
(N = 125) 
Control 
 (N = 132) P 
Female 64 (49.6) 66 (51.6) 0.75 64 (49.6) 66 (51.6) 0.75 62 (49.6) 68 (51.5) 0.76 
Age, mean (SD) 67.16 (13.38) 69.55 (12.64) 0.14 68.49 (13.03) 68.22 (13.08) 0.87 67.30 (13.12) 69.35 (12.91) 0.21 
Insurance          
1. Medicare 92 (71.3) 96 (75.0) 0.69 93 (72.1) 95 (74.2) 0.70 88 (70.4) 100 (75.8) 0.35 
2. Medicaid 10 (7.8) 7 (5.5)  7 (5.4) 10 (7.8)  10 (8.0) 7 (5.3)  
3. Commercial 14 (10.9) 16 (12.0)  16 (12.4) 14 (10.9)  13 (10.4) 17 (12.9)  
4. None 13 (10.1) 9 (7.0)  13 (10.1) 9 (7.0)  14 (11.2) 8 (6.1)  
Living Conditions          
1.With spouse/caregiver 88 (68.2) 88 (68.8) 0.69 87 (67.4) 89 (69.5) 0.71 83 (66.4) 93 (70.5) 0.56 
2. Alone 40 (31.0) 37 (28.9)  39 (30.2) 38 (29.7)  41 (32.8) 36 (27.3)  
3. Other 1 (0.8) 2 (1.6)  2 (1.6) 1 (0.8)  1 (0.8) 2 (1.5)  
4. Homeless 0 (0.0) 1 (0.8)  1 (0.8) 0 (0.0)  0 (0.0) 1 (0.8)  
PAM, mean (SD) 54.73 (14.93) 53.83 (12.87) 0.60 53.17 (13.44) 55.41 (14.36) 0.20 54.99 (15.00) 53.61 (12.85) 0.43 
Admissions, mean (SD) 1.87 (1.44) 1.71 (1.29) 0.36 1.81 (1.44) 1.77 (1.29) 0.78 1.86 (1.44) 1.73 (1.30) 0.45 
ED visits, mean (SD) 0.84 (1.86) 0.70 (1.60) 0.54 0.82 (1.87) 0.72 (1.58) 0.63 0.80 (1.77) 0.74 (1.70) 0.79 
CHF admissions, mean (SD) 0.46 (0.65) 0.40 (0.59) 0.45 0.46 (0.67) 0.40 (0.57) 0.45 0.46 (0.65) 0.40 (0.59) 0.48 
CHF hospital days, mean (SD)  2.02 (3.69) 2.04 (4.00) 0.97  1.91 (3.19)   2.15 (4.41) 0.63 2.02 (3.73) 2.04 (3.96) 0.98 
LOS index, mean (SD) 5.33 (4.70) 5.14 (3.80) 0.72 5.32 (4.23) 5.16 (4.32) 0.76 5.24 (4.67) 5.23 (3.87) 0.99 
COPD 49 (38.0) 42 (32.8) 0.39 46 (35.7) 45 (35.2) 0.93 48 (38.4) 43 (32.6) 0.33 
CEVD 64 (49.6) 53 (41.4) 0.19 58 (45.0) 59 (46.1) 0.86 62 (49.6) 55 (41.7) 0.20 
Chronic pain 29 (22.5) 23 (18.0) 0.37 28 (21.7) 24 (18.8) 0.56 28 (22.4) 24 (18.2) 0.40 
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Diabetes 64 (49.6) 54 (42.2) 0.23 59 (45.7) 59 (46.1) 0.95 61 (48.8) 57 (43.2) 0.37 
AMI 33 (25.6) 35 (27.3) 0.75 33 (25.6) 35 (27.3) 0.75 32 (25.6) 36 (27.3) 0.76 
Renal disease 44 (34.1) 32 (25.0) 0.11 38 (29.5) 38 (29.7) 0.97 42 (33.6) 34 (25.8) 0.17 
Obesity 54 (41.9) 44 (34.4) 0.22 50 (38.8) 48 (37.5) 0.84 52 (41.6) 46 (34.8) 0.27 
Abbreviations: PAM, Patient Activation Measure; ED, Emergency Department; CHF, Congestive Heart Failure; COPD, chronic obstructive pulmonary disease; 
CEVD, cerebrovascular disease; AMI, acute myocardial infarction; LOS, length of stay. Values reported as No. (%) unless otherwise noted.  
Table 2: Baseline characteristics of study participants, assigned to treatment under three different allocation methods, evaluated using 
Optimal Discriminant Analysis (ODA). Values represent cut-points (or assignment rules for categorical measures) on the 
characteristic, and values in parentheses represent sensitivity (for treatment) and specificity (for controls), as a percent. 
 
  Block randomization  Minimization Classification Tree Analysis 
Characteristic Treatment (N=129) 
Control 
(N=128) ESS P< 
Treatment 
(N=129) 
Control 
(N=128) ESS P< 
Treatment 
(N=125) 
Control 
(N=132) ESS P< 
Age < 74.6 (73.64) 
> 74.6 
(38.28) 11.92 0.30 
> 64.4 
(69.77) 
< 64.4 
(36.72) 6.49 0.94 
< 59.1 
(27.20) 
> 59.1 
(84.09) 11.29 0.36 
Female = 1 (50.39) 
= 0 
(51.56) 1.95 0.81 
= 0 
(50.39) 
= 1 
(51.56) 1.95 0.81 
= 1 
(50.40) 
= 0 
(51.52) 1.92 0.80 
Insurance = 2,4 (17.83) 
= 1,3 
(87.50) 5.33 0.62 
= 3,4 
(22.48) 
= 1,2 
(82.03) 4.51 0.74 
= 2,4 
(19.20) 
= 1,3 
(88.64) 7.84 0.30 
Living cond.  = 2 (31.01) 
= 1,3,4 
(71.09) 2.1 0.86 
> 1 
(32.56) 
= 1 
(69.53) 2.09 0.88 
= 2 
(32.80) 
= 1,3,4 
(72.73) 5.53 0.44 
PAM > 58.2 (34.88) 
< 58.2 
(75.00) 9.88 0.33 
< 51.4 
(54.26) 
> 51.4 
(54.69) 8.95 0.43 
> 58.2 
(36.00) 
< 58.2 
(75.76) 11.76 0.19 
Admissions > 2 (18.60) 
< 2 
(85.94) 4.54 0.71 
> 5  
(3.88) 
< 5 
(97.66) 1.53 0.99 
> 2 
(18.40) 
< 2 
(85.61) 4.01 0.77 
ED visits > 1 (17.83) 
< 1 
(86.72) 4.55 0.69 
> 1 
(17.05) 
< 1 
(85.94) 2.99 0.92 
> 2 
(17.60) 
< 2 
(86.36) 3.96 0.75 
CHF admits > 0 (38.76) 
= 0  
(65.62) 4.38 0.59 
> 1  
(6.98) 
< 1 
(96.09) 3.07 0.77 
> 0 
(38.40) 
= 0 
(65.15) 3.55 0.67 
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CHF days > 1 (38.76) 
< 1 
(67.97) 6.73 0.49 
> 1 
(37.21) 
< 1 
(66.41) 3.62 0.93 
> 1 
(38.40) 
< 1 
(67.42) 5.82 0.62 
LOS index < 5 (69.77) 
> 5 
(35.16) 4.92 0.91 
> 5 
(37.21) 
< 5 
(71.87) 9.08 0.36 
< 5 
(70.40) 
> 5 
(35.61) 6.01 0.77 
COPD = 1 (37.98) 
= 0 
(67.19) 5.17 0.44 
= 1 
(35.66) 
= 0 
(64.84) 0.5 0.99 
= 1 
(38.40) 
= 0 
(67.42) 5.82 0.37 
CEVD = 1 (49.61) 
= 0 
(58.59) 8.21 0.21 
= 0 
(55.04) 
= 1 
(46.09) 1.13 0.9 
= 1 
(49.60) 
= 0 
(58.33) 7.93 0.22 
Chronic pain = 1 (22.48) 
= 0 
(82.03) 4.51 0.44 
= 1 
(21.71) 
= 0 
(81.25) 2.96 0.65 
= 1 
(22.40) 
= 0 
(81.82) 4.22 0.45 
Diabetes = 1 (49.61) 
= 0 
(57.81) 7.42 0.27 
= 0 
(54.26) 
= 1 
(46.09) 0.36 0.99 
= 1 
(48.80) 
= 0 
(56.82) 5.62 0.38 
AMI = 0 (74.42) 
= 1 
(27.34) 1.76 0.78 
= 0 
(74.42) 
= 1 
(27.34) 1.76 0.78 
= 0 
(74.40) 
= 1 
(27.27) 1.67 0.78 
Renal = 1 (34.11) 
= 0 
(65.62) 9.11 0.14 
= 0 
(70.54) 
= 1 
(29.69) 0.23 0.99 
= 1 
(33.60) 
= 0 
(74.24) 7.84 0.18 
Obesity = 1 (41.86) 
= 0 
(65.62) 7.49 0.25 
= 1 
(38.76) 
= 0 
(62.50) 1.26 0.91 
= 1 
(41.60) 
= 0 
(65.15) 6.75 0.31 
 
Abbreviations: PAM, Patient Activation Measure; ED, emergency department; CHF, congestive heart failure; COPD, chronic obstructive pulmonary disease; 
CEVD; cerebrovascular disease; AMI, acute myocardial infarction; LOS, length of stay; ESS, effect strength for sensitivity. 
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Figure 1:  Interactive (1a, 1b) and parabolic (1c, 1d) CTA models identified for imbalanced subsamples. 
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